Focusing on the coronavirus vaccine is a useful way for China to squeeze out room for more difficult questions about its initial response to COVID-19.
Medical innovation is often accelerated in a time of crisis.
A sports management scholar weighs in on the potential consequences of holding Big Ten football games in the fall instead of waiting for a vaccine or better safety procedures.
From adenoviruses to RNA: the pros and cons of different COVID vaccine technologies
A tragic error showed how complicated it can be to distribute vaccines on a mass scale.
Our best shot at ending the pandemic is by achieving herd immunity through widespread use of a vaccine. But that won't happen unless people believe it's safe.
Another day, another politicised vaccine.
A primer on Sinovac, Sinopharm and CanSino, and their prospects for achieving a world first for coronavirus.
Church leaders have raised concerns over a COVID-19 vaccine produced using cells derived from aborted foetuses. But the Vatican has already ruled such vaccines 'morally separate' from the abortions.
Thousands of people around the world have said they are willing to be exposed to COVID-19 to test new vaccines. Since we don't fully understand the long-term effects of the disease, is this ethical?
The vaccine hasn't completed phase 3 trials, so we can't be sure it will be safe and effective for all. The Australian government's deal is contingent on these trials being successful.
The federal government has signed a letter of intent with drug company AstraZeneca to supply a COVID-19 vaccine to Australia.
As Russia fast tracks a coronavirus vaccine, scientists worry about skipped safety checks – and the potential fallout for trust in vaccines if something ends up going wrong.
If the vaccine does not protect individuals from infection, those who have been vaccinated could falsely believe they are protected.
Whether a coronavirus vaccine involves a live virus or a carrier organism, it will probably require more than one injection. But that's not a bad thing.
The Russian cyberthreat, now targeting coronavirus vaccine research, goes back over three decades, extends into the country's educational systems and criminal worlds, and shows no signs of letting up.
Jane Halton on the risk of ‘vaccine nationalism’
Michelle Grattan discusses the coronavirus crsis with chair of CEPI Jane Halton
South Africa is trialling a vaccine for COVID-19. Here's what you need to know about it.
Tobacco has imposed a terrible toll on global health, but it could be used to produce the molecules we need to fight COVID-19.
The UK is investing heavily in preparation for mass manufacturing of a working COVID-19 vaccine.